DRL gets orders worth $20 million

Our Corporate Bureau

Mumbai, Aug 3: DRL officials on Friday confirmed that the company has already bagged orders worth $20 million for generic flouxetine 40 mg capsules in the US and shipments will be made in due course.
Analysts say that though prices of generic drugs are significantly lower the original patented version, DRL can cash in on its 180-day marketing exclusivity for fluoxetine.